Meredith S. Manning
Corporate Officer/Principal chez SOLENO THERAPEUTICS, INC.
Postes actifs de Meredith S. Manning
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| SOLENO THERAPEUTICS, INC. | Corporate Officer/Principal | 24/01/2024 | - |
Historique de carrière de Meredith S. Manning
Anciens postes connus de Meredith S. Manning
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ADICET BIO, INC. | Corporate Officer/Principal | 18/09/2018 | 06/12/2019 |
| BAXTER INTERNATIONAL INC. | Sales & Marketing | 01/01/2013 | 01/07/2015 |
| PHARMAESSENTIA CORPORATION | Corporate Officer/Principal | - | - |
Formation de Meredith S. Manning
| The Colorado College | Undergraduate Degree |
| The University of Chicago Booth School of Business | Masters Business Admin |
Statistiques
Internationale
| Etats-Unis | 6 |
| Taïwan | 2 |
Opérationnelle
| Corporate Officer/Principal | 3 |
| Undergraduate Degree | 1 |
| Masters Business Admin | 1 |
Sectorielle
| Health Technology | 5 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| BAXTER INTERNATIONAL INC. | Health Technology |
| SOLENO THERAPEUTICS, INC. | Health Technology |
| PHARMAESSENTIA CORPORATION | Health Technology |
| Entreprise privées | 1 |
|---|---|
resTORbio, Inc.
 resTORbio, Inc. BiotechnologyHealth Technology resTORbio, Inc. is a clinical-stage biopharmaceutical company. The firm engages in the development and commercialization of medicines for aging-related diseases and conditions. It offers an immunotherapy under the TORC1 program. The company was founded by Chen Schor and Joan Mannick on July 5, 2016 and is headquartered in Boston, MA. | Health Technology |
- Bourse
- Insiders
- Meredith S. Manning
- Expérience